This is not a wise ass reply my friend, but based on market interest over the past couple years, it seems to worth zero. Maybe next week will find out someone thinks at least one of them is worth something.

Personally I don’t see anyone wanting Lympro or Nuropro. MS Precise has some actual commercialization potential. So we will see.